Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial (Q57422643)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial	article

Statements

scholarly article

0 references

Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial (English)

0 references

1 reference

based on heuristic

inferred from title

Acute decompensated heart failure

1 reference

based on heuristic

inferred from title

object named as

Gad Cotter

6

0 references

object named as

Marco Metra

1

0 references

Piotr Ponikowski

object named as

Piotr Ponikowski

14

0 references

object named as

John G.F. Cleland

5

0 references

3

object named as

Karen Chiswell

0 references

John R Teerlink

15

object named as

John R. Teerlink

0 references

Adriaan A Voors

16

object named as

Adriaan A. Voors

0 references

Christopher M O'Connor

17

object named as

Christopher M. O'Connor

0 references

Michael M Givertz

10

object named as

Michael M. Givertz

0 references

Barry M. Massie

13

object named as

Barry M. Massie

0 references

Howard C Dittrich

8

object named as

Howard C. Dittrich

0 references

Robert J. Mentz

2

object named as

Robert J. Mentz

0 references

Beth A. Davison

7

object named as

Beth A. Davison

0 references

George A. Mansoor

12

object named as

George A. Mansoor

0 references

Daniel M Bloomfield

4

object named as

Daniel M. Bloomfield

0 references

Valentina Lazzarini

11

object named as

Valentina Lazzarini

0 references

author name string

Mona Fiuzat

9

0 references

publication date

27 November 2014

0 references

European Journal of Heart Failure

0 references

17

0 references

1

0 references

109-118

0 references

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Rehospitalization for heart failure: problems and perspectives

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Trends in prevalence and outcome of heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

The diversity of heart failure in a hospitalized population: the role of age.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Heart failure in elderly patients: distinctive features and unresolved issues

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment e

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospital

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

National patterns of heart failure hospitalizations and mortality by sex and age.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Frailty assessment in the cardiovascular care of older adults

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Frailty and healthcare utilization among patients with heart failure in the community

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

21 January 2018

Pulse pressure and risk for myocardial infarction and heart failure in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.207

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.207

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57422643&oldid=2067212578"